Biography and Research Information
OverviewAI-generated summary
Mohammad Mamun Alam's research focuses on virology and the development of antiviral strategies. His work has investigated monoclonal antibody-based treatments and prevention for HIV-1, including the construction, purification, and expression of cell line-based anti-HIV-1 antibodies. He has also explored the efficacy of combination therapies involving small antibodies and fusion inhibitors as novel anti-retroviral treatments. Alam's recent publications examine immune responses to COVID-19 vaccines in Bangladeshi populations, computational predictions for Nipah virus vaccines, and the antiviral potential of various compounds against viruses such as Dengue and Chikungunya. He has also contributed to studies on SARS-CoV-2 variants and cross-neutralization between SARS-CoV-2 and Influenza A. Alam has experience leading a research team and collaborating with both local pharmaceutical companies and international organizations.
Metrics
- h-index: 6
- Publications: 17
- Citations: 102
Selected Publications
-
Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines (2025)
Collaboration Network
Top Collaborators
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Similar Researchers
Based on overlapping research topics